[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371040-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371040-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mir-101-3p-represses-the-migratory-and-invasive-abilities-of-ovarian-cancer-cells","miR-101-3p represses the migratory and invasive abilities of ovarian cancer cells","","Study evaluates how miR-101-3p affects ovarian cancer cell migration and invasion using SKOV3 and OVCAR-3 models. miR-101-3p was delivered by mimic transfection, and changes in viability, motility, and invasiveness were measured with CCK8, wound healing, and Transwell assays. RNA sequencing profiled differential gene expression. miR-101-3p reduced viability, migration, and invasion in both lines, while downstream transcripts showed cell-type-specific regulation, supporting a tumor-suppressive role with complex network behavior.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mir-101-3p-represses-the-migratory-and-invasive-abilities-of-ovarian-cancer-cells/371040/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mir-101-3p-represses-the-migratory-and-invasive-abilities-of-ovarian-cancer-cells/371040.png","ImageObject",300,407,{"name":42,"@type":43},"nayy☆","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of this study on miR-101-3p in ovarian cancer?","Question",{"text":63,"@type":64},"To determine how miR-101-3p influences the migratory and invasive abilities of ovarian cancer cells, specifically in SKOV3 and OVCAR-3 cell lines.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were miR-101-3p effects on migration and invasion tested experimentally?",{"text":68,"@type":64},"miR-101-3p was overexpressed using mimic transfection, and effects on viability, migration, and invasion were evaluated with CCK8, wound healing, and Transwell assays.",{"name":70,"@type":61,"acceptedAnswer":71},"What overall conclusion does the study reach about miR-101-3p?",{"text":72,"@type":64},"miR-101-3p functions as a tumor suppressor in ovarian cancer, with downstream gene regulation showing a paradoxical, cell-type-specific network that likely requires further mechanistic study.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371040,1790802184,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Chen et al. BMC Cancer (2025) 25:1864 [https://doi.org/10.1186/s12885-025-15280-9](https://doi.org/10.1186/s12885-025-15280-9)  \nBMC Cancer  \nRESEARCH Open Access  \nmiR-101-3p represses the migratory and invasive abilities of ovarian cancer cells  \nLi Chen 1†, Haizhou Ji 1†, Zuol ian Xie 1, Yiting Lin 1, Ling Li 1, Liang Lin 1* and An Lin 1*  \nAbstract  \nBackground The study aimed to assess the effects of miR-101-3p on the migratory and invasive abilities of ovarian cancer cells, specifically in the SKOV3 and OVCAR-3 cell lines.  \nMethods The expression of miR-101-3p was overexpressed in SKOV3 and OVCAR-3 ovarian cancer cell lines via mimic transfection. The effects on cell viability, migration, and invasion were evaluated using CCK8, wound healing, and Transwell assays, respectively. RNA sequencing was subsequently performed to identify differential ly expressed genes.  \nResults Overexpression of miR-101-3p significantly decreased cell viability, migration, and invasion in both SKOV3 and OVCAR-3 cells. Transcriptomic analysis identified numerous differential ly expressed genes, including FN-1 and CXCL8 . Intriguingly, while miR-101-3p suppressed FN-1 mRNA in SKOV3 cells, it led to an increase in both FN-1 and CXCL8 mRNA levels in OVCAR-3 cells, despite inhibiting their invasive phenotype.  \nConclusions Our study confirms that miR-101-3p acts as a tumor suppressor in ovarian cancer. The paradoxical regulation of downstream gene transcripts highlights a complex, cell-type-specific regulatory network. This suggests that the overall phenotypic effect of miR-101-3p is an integrated outcome of modulating multiple targets, rather thana linear pathway, and underscores its potential as a therapeutic target requiring further mechanistic study.  \nClinical trial number Not applicable.  \nKeywords MiR-101-3p, Ovarian cancer, Invasion, Migration, C-X-C motif ligand 8  \n†Li Chen and Haizhou Ji contributed equally to this work.  \n*Correspondence:  \nLiang Lin [lianglin@fjzlhospital.com](lianglin@fjzlhospital.com)[ ](lianglin@fjzlhospital.com)An Lin[anlin@fjzlhospital.com](anlin@fjzlhospital.com)  \n1Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 420, Fuma Road, Fuzhou 350014, China  \nBackground  \nOvarian cancer represents the deadliest gynecologic cancer, with a lifetime risk approximating 1 in 50 to 70 women [1, 2]. According to GLOBOCAN 2020, there were about 313,959 newly diagnosed ovarian cancer cases in 2020, with 207,252 related deaths [3]. Individuals aged 60–64 years are the most affected, with majority of ovarian cancer diagnoses occurring in individuals over 50 years of age [1, 2]. Ovarian cancer diagnosis is difficult, as there are no reliable screening tests and symptoms for this malignancy, which results in most diagnoses occurring at late disease stages [4, 5]. Unfortunately, even with the best care, 5-year overall survival in ovarian cancer is low, at around 45% for all cases, and 89%, 70%, 36%,  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/.  \nChen et al. BMC Cancer (2025) 25:1864  \nand 17% in individuals with stage I to IV d","cbCaibUl9smUiOGF","https://ap.wps.com/l/cbCaibUl9smUiOGF","pdf",2073580,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Epidemiology and clinical challenges\n# Molecular context\n## EMT and metastasis\n# Rationale\n## miRNA-101-3p in cancer","[{\"question\":\"What is the main objective of this study on miR-101-3p in ovarian cancer?\",\"answer\":\"To determine how miR-101-3p influences the migratory and invasive abilities of ovarian cancer cells, specifically in SKOV3 and OVCAR-3 cell lines.\"},{\"question\":\"How were miR-101-3p effects on migration and invasion tested experimentally?\",\"answer\":\"miR-101-3p was overexpressed using mimic transfection, and effects on viability, migration, and invasion were evaluated with CCK8, wound healing, and Transwell assays.\"},{\"question\":\"What overall conclusion does the study reach about miR-101-3p?\",\"answer\":\"miR-101-3p functions as a tumor suppressor in ovarian cancer, with downstream gene regulation showing a paradoxical, cell-type-specific network that likely requires further mechanistic study.\"}]","miR-101-3p represses the migratory and invasive abilities of ovarian cancer cells | PDF",1790191097,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/06ec470754c4f88dccc9c62e8c3aa2d2.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5f1c38999e9ce4ee780d60062f5d0fd.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21b0cdbe2e2982ec2bff1799cdf778ce.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea504a80a8c4884e4bd7be2859d22b29.webp",980,1306]